References
- Ali R, Cusi K. New diagnostic and treatment approaches in non-alcoholic fatty liver disease. Ann Med. 2009; 41(4): 265-78. PubMed | Google Scholar
- Erickson SK. Non Alcoholic Liver Disease. J Lipid Res. 2009; 50 Suppl: S412-S416. PubMed | Google Scholar
- Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ. 2005; 172(7):899-905. PubMed | Google Scholar
- Cusi K. Nonalcoholic fatty liver disease in type 2 Diabetes Mellitus. Curr Opin Endocrinol Diabetes Obes. 2009; 16(2): 141-149. PubMed | Google Scholar
- McCullough AJ. Epidemiology of the metabolic syndrome in the USA. J Dig Dis.2011;12 (5):333-40. doi: 10.1111/j.1751-2980.2010.00469.x. PubMed | Google Scholar
- Foster T, Anania FA, Li D, Katz R, Budoff M. The prevalence and clinical correlates of non-alcoholic fatty liver disease in African Americans: The multiethnic study of atherosclerosis (MESA).Dig Dis Sci. 2013; 58(8):2392-8. PubMed | Google Scholar
- Lazo M,Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, Koteish A, Brancati FI, Clark JM. Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2013; 178(1): 38-45. PubMed | Google Scholar
- Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010; 28(1): 155-61. PubMed | Google Scholar
- Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346:1221-1231. PubMed | Google Scholar
- Clark J, Diehl A. Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep. 2002; 3:210-215. PubMed | Google Scholar
- Targher G, Bertolini L, Padovani R, Rodella S,
Zoppini G, Pichiri I, Sorgato C, Zenari L, Bonora E.Prevalence
of non-alcoholic fatty liver disease and its association
with cardiovascular disease in
patients with type 1 diabetes. J Hepatol. 2010;53(4):713-8.
doi: 10.1016/j.jhep.2010.04.030. PubMed | Google
Scholar
- Targher G, Bertolini L, Chonchol M, Rodella S, Zoppini G, Lippi G, Zenari L, Bonora E.Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia. 2010;53(7):1341-8. doi: 10.1007/s00125-010-1720-1. PubMed | Google Scholar
- Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007;13(10): 1579-1584. PubMed | Google Scholar
- Kruger FC, Daniels C, Kidd M, Swart G, Brundyn K, Van Rensburg C, Kotze MJ.Non-alcoholic fatty liver disease in the Western Cape: a descriptive analysis.S Afr Med J. 2010;100 (3):168-171. PubMed | Google Scholar
- International Diabetes Federation. IDF DIABETES
ATLAS- 6th edition.2013. Brussels, Belgium. Accessed on March 16, 2015. Google
Scholar
- American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes care. 2004; 27: Suppl 1S5-S10. PubMed | Google Scholar
- World Health Organization. Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation. Geneva WHO Press. 2011; 6th edition. Google Scholar
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. JAMA. 2003; 289:2560. PubMed | Google Scholar
- Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, American Heart Association: implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227-39. PubMed | Google Scholar
- Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, Clark JM. Diagnosis accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082-1090. PubMed | Google Scholar
- Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol. 2009;51(3):433- 445. PubMed | Google Scholar
- Fleiss JL. Statistical Methods for Rates and Pro- portions. New York: Wiley. 1981; 2nd ed. Google
Scholar
- Onyekwere CA, Ogbera AO, Balogun BO. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community. Ann Hepatol. 2011;10(2):119-24. PubMed | Google Scholar
- Prashanth M, Ganesh HK, Vima MV, John M, Bandgar T, Joshi SR, Shah SR, Rathi PM, Joshi AS, Thakkar H, Menon PS, Shah NS. Prevalence of Nonalcoholic fatty liver disease in patients with type 2 Diabetes Mellitus. J Assoc Physicians India(JAPI). 2009; 57:205-210. PubMed | Google Scholar
- Leite, NC, Salles GF, Araujo AL, Villela-Nogueira CA, Cardoso CR. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver International. 2009; 29(1):113-119. PubMed | Google Scholar
- Chan WK, Tan AT, Vethakkan SR, Tah PC, Vijayananthan A, Goh KL.Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia. J Gastroenterol Hepatol. 2013;28(8):1375-83. PubMed | Google Scholar
- Pan J, Fallon MB. Gender and racial differences in non-alcoholic fatty liver disease. World J Hepatol. 2014; 6(5):274-283. PubMed | Google Scholar
- Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40(12):1461-5. PubMed | Google Scholar
- Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, Gudnason V, Eiriksdottir G, Garcia ME, Launer LJ, Nalls MA, Clark JM, Mitchell BD, Shuldiner AR, Butler JL, Tomas M, Hoffmann U, Hwang SJ, Massaro JM, O'Donnell CJ, Sahani DV, Salomaa V, Schadt EE, Schwartz SM, Siscovick DS. GOLD Consortium: Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;7(3):e1001324. PubMed | Google Scholar